Ligand Pharmaceuticals IncorporatedLGNDNASDAQ
LOADING
|||
| Metric | Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|---|---|
| Revenue | 164 | 242↑47.7% | 196↓18.8% | 131↓33.1% | 167↑27.3% |
| Gross Profit | 133 | 179↑34.7% | 143↓20.0% | 96↓32.9% | 156↑62.1% |
| Operating Income | 38 | 104↑176.9% | 3↓97.1% | 12↑293.2% | -23↓289.3% |
| Net Income | -3 | 57↑2014.2% | -33↓158.4% | 52↑256.3% | -4↓107.7% |
| EBITDA | 57 | 143↑151.9% | 81↓43.1% | 101↑24.2% | 41↓59.5% |
| EPS Diluted | -0.18 | 3.34↑1955.6% | -1.98↓159.3% | 2.94↑248.5% | -0.22↓107.5% |